SCHEMBL2074481

SCHEMBL2074481

CCOC(=O)c1cc2c([nH]1)C(Cc1ccc(-c3ccccc3)cc1)CC2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 1/20 0.47
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
LMNA P02545 3/20 0.44
GAA P10253 3/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 3/20 0.44
ATM Q13315 2/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
GLA P06280 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.41
HPGDS O60760 1/20 0.41
CACNA1D Q01668 2/20 0.40
MMP2 P08253 3/20 0.39
MMP13 P45452 2/20 0.39
MMP14 P50281 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1005338 0.93 RAB9A (0.44) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL2074473 0.85 CYP26A1 (0.53) CYP26A1ALDH1A1LMNAGAAMEN1
SCHEMBL1003729 0.82 ATM (0.46) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL1003271 0.82 ALDH1A1 (0.45) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL1002876 0.80 BCHE (0.42) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL2075803 0.78 ALOX15 (0.38) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL12777444 0.77 DDB1 (0.46) CYP26A1KDM4EMAPTHPGDHSD17B10
SCHEMBL1003795 0.77 DDB1 (0.46) CYP26A1KDM4EMAPTHPGDHSD17B10
SCHEMBL1005108 0.75 HRH3 (0.43) ALDH1A1KDM4ELMNAGAAMAPT
SCHEMBL1003759 0.72 ESR1 (0.51) CYP26A1ALDH1A1KDM4EGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
US-7902252-B2 Inhibitors of D-amino acid oxidase SEPRACOR, INC. (US) 2011-03-08 US disclosed
WO-2011011330-A2 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2011-01-27 WO disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029737-A1 INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, ACHE CYP26A1 2705/4885ALDH1A1 465/4885KDM4E 1859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.